ArticleFrontiers in pharmacology2023

In-silico studies to recognize repurposing therapeutics toward arginase-I inhibitors as a potential onco-immunomodulators.

Magdi E A Zaki et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.